Table 2.

Multivariate analysis of factors associated with poor prognosis in patients with anti-NMDARE.

Variable and Intercept	β Coefficient	OR (95%CI)	P-value
Age	0.096	1.10 (1.04–1.17)	0.002
Behavioral changes	1.451	4.27 (1.25–14.57)	0.021
Consciousness disorder	2.046	7.73 (2.29–26.12)	0.001
Movement disorder	1.964	7.13 (2.14–23.76)	0.001
Autonomic dysfunction	−0.196	0.82 (0.12–5.44)	0.839
Viral prodrome	0.831	2.30 (0.74–7.13)	0.151
CSF WBC count (>20 cell/μL)	1.319	3.74 (1.16–12.04)	0.027
Immunotherapy latency (>4 wk)	1.642	5.17 (1.44–18.53)	0.012
Intercept	−7.359	NA	NA

NA, not applicable; anti-NMDARE, anti-N-methyl-D-aspartate receptor encephalitis; CSF, cerebrospinal fluid; WBC, white blood cell; mRS, modified Rankin Scale.